CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The IgG (1st IS) test can be used in random access mode and integrated into existing workflows without batch processing. Results are delivered on the company’s immunoassay analyzers, including its DxI 800 high-throughput analyzer, which is capable of processing up to 200 Access SARS-CoV-2 IgG (1st IS) samples per hour. The test is available to all customers in countries accepting the CE mark and to customers throughout the United States and Puerto Rico under FDA policy D.
Pages: 1 2